Sunday, October 16 - Thursday, October 20, 2022
Newborn screening programs are a vital public health resource that enable millions of infants to benefit from early detection and intervention of genetic, endocrine, metabolic, hearing, and critical congenital heart conditions. Yet in many jurisdictions across the country newborn screening data can be fragmented, siloed, and subject to different screening procedures, methods, turnaround times, and approaches for interpreting results.
Altarum helps states and jurisdictions address these gaps, creating a more streamlined and uniform system of newborn screening and reporting.
At the 2022 Association of Public Health Laboratories (APHL) Newborn Screening Symposium, Altarum’s Craig Newman and Charisse LaVell will present a poster on the HRSA-funded Innovations in Newborn Screening Interoperability (INBSI) program. Craig will also give an oral presentation on the program as part of the Health Information Technology (HIT) session. Through this program, Altarum provides technical assistance to states to advance their newborn screening interoperability, from building a program portal and assessing state readiness to providing direct technical assistance and creating customized roadmaps for enhancing interoperability.
In its first in-person gathering in three years, the APHL Newborn Screening Symposium addresses state, national and international newborn screening, genetic testing, and policy issues important to public health newborn screening systems. View a full program agenda and learn more about the APHL NBS2022 Preliminary Program.
Altarum brings two decades of experience advancing states’ interoperability capabilities, which includes developing Fast Healthcare Interoperability Resources (FHIR) solutions; building applications that support information exchange for disease surveillance and care coordination; and helping to create national standards for electronic birth defect reporting, newborn screening early hearing detection and intervention, and critical congenital heart defects/disease.